Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Nora AI
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

Niles Noblitt, through Sacajo Investments LLC, makes investment in Episurf through an arrangement with CEO Pål Ryfors

Episurf Medical

In order to facilitate settlement of an acquisition of 9,526,170 Class B shares in Episurf Medical AB (publ) ("Episurf" or the "Company") by Sacajo Investments LLC ("Sacajo"), a trust with the Company's Senior Advisor Niles Noblitt as first member, Sacajo and Pål Ryfors, CEO of Episurf, have agreed that Pål Ryfors shall hold the shares during an interim period. Consequently, Pål Ryfors will acquire 9,526,170 Class B shares in Episurf from Sacajo for a purchase price of SEK 2,286,280.80, corresponding to SEK 0.24 per share. Payment for the shares is made by Pål Ryfors issuing a promissory note to Sacajo. The promissory note is interest free and Sacajo will bear all taxes and other costs related to the share transfer. The transferred shares are subject to a put and call option, pursuant to which Sacajo may request to acquire all 9,526,170 Class B shares from Pål Ryfors and Pål Ryfors may request to sell all 9,526,170 Class B shares to Sacajo, in both cases for a purchase of SEK 0.24 per share.

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.